Icahn School of Medicine at Mount Sinai | sciencenewsnet.in

Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding

July 8, 2020 sarah Jonas Antibody Therapy, Clinical Trial, Convalescent Plasma, convalescent plasma therapy, covid 19 therapies, covid 19 treatments, covid 19 trials, COVID Research, COVID Treatment, COVID-19, Icahn School of Medicine at Mount Sinai, Mount Sinai, Mount Sinai Health System

Mount Sinai and Emergent to conduct clinical trials to evaluate COVID-HIG for post-exposure prophylaxis of COVID-19 in front-line health care workers and to support a potential Expanded Access Program for military personnel with funding from the U.S. Department of Defense
– ImmunoTek to extend operating license and provide training to Mount Sinai to establish onsite plasma collection to support production of COVID-HIG

Read more

Research Results

Mount Sinai Researchers Find That COVID-19 Patients with HIV Did Not Experience Poorer Outcomes

June 29, 2020 sarah Jonas Clinical Infectious DIseases, COVID-19, HIV, Icahn School of Medicine at Mount Sinai, Informatics, Mount Sinai Health System, SARS-CoV-2

Patients with HIV who were hospitalized with COVID-19 did not experience poorer outcomes compared to a similar comparison group of patients.

Read more

Research Results

Researchers Identify Distinct Subtypes of Polycystic Ovary Syndrome With Novel Genetic Associations

June 23, 2020 sarah Jonas Clinical Outcomes, Diagnosis, Endocrinology, Genetics, Health, Hormones, Icahn School of Medicine at Mount Sinai, Medicine, Mount Sinai Health System, Science, Treatment

Mount Sinai researchers have for the first time identified reproductive and metabolic subtypes of polycystic ovary syndrome (PCOS) that are associated with novel gene regions.

Read more

Mount Sinai seeks EUA from Food and Drug Administration for potential quantitative serologic test for COVID-19

June 17, 2020 sarah Jonas Bio-Techne, Carlos Cordon-Cardo, Convalescent Plasma, Coronavirus, COVID-19, Emergency Use Authorization, Florian Krammer, Icahn School of Medicine at Mount Sinai, Infectious Disease, Kantaro Biosciences, Medicine, Microbiology, Mount Sinai Health System, Mount Sinai Innovation Partners, Nature Medicine, Science, U.S. Food And Drug Administration

If authorized for quantitative use, the assay could be used to provide a numeric result for the concentration of neutralizing anti-COVID-19 antibodies in plasma.

Read more

Mount Sinai Health System Appoints Kristin Myers, MPH, as Executive Vice President, Chief Information Officer, and Dean for Information Technology

June 9, 2020 sarah Jonas chief information officer, digital health, Icahn School of Medicine at Mount Sinai, Information Technology, Mount Sinai Health System

Mount Sinai Health System has appointed Kristin Myers, MPH, as Executive Vice President, Chief Information Officer, and Dean for Information Technology.

Read more

Two Widely-Used Drugs for Erectile Dysfunction Could Be Repurposed to Treat Osteoporosis

June 8, 2020 sarah Jonas Aging, Aging Population, Bone Loss, Erectile Dysfunction, Icahn School of Medicine at Mount Sinai, Mone Zaidi, Mount Sinai Bone Program, Mount Sinai Health System, Osteoporosis

Read more

Research Results

Heart Injury Among Hospitalized COVID-19 Patients Associated with Higher Risk of Death

June 8, 2020 sarah Jonas coronavirus and heart, coronavirus deaths, covid 19, Covid and heart, COVID-19, Heart Damage, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, valentin fuster

Study findings may help doctors better triage coronavirus patients admitted to the hospital

Read more

Research Results

Researchers Identify Mechanisms That Make Skin a Protective Barrier

May 28, 2020 sarah Jonas Eczema, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Psoriasis

Study Could Help Doctors Understand and Treat Common Conditions

Read more

Mount Sinai Health System and Renalytix Form Joint Venture, Kantaro Biosciences, To Develop and Scale Production of COVID Antibody Test Kits

May 19, 2020 sarah Jonas antibody testing, Coronavirus, COVID-19, Florian Krammer, Health, Health Care, Icahn School of Medicine at Mount Sinai, Medicine, Microbiology, Mount Sinai Health System, Mount Sinai Innovation Partners, Nature Medicine, Pathology, Production, SARS-CoV-2, Science, Testing

– Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution
– Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July

Read more

Research Results

Mount Sinai First in U.S. to Use Artificial Intelligence to Analyze Coronavirus (COVID-19) Patients

May 19, 2020 sarah Jonas Algorithm, China, Coronavirus, COVID-19, Disease Diagnosis, Icahn School of Medicine at Mount Sinai, Imaging, Mount Sinai Health System

Mount Sinai researchers are the first in the country to use artificial intelligence (AI) combined with imaging, and clinical data to analyze patients with coronavirus disease (COVID-19).

Read more

Mount Sinai Launches New Institute for Health Equity Research

May 14, 2020 sarah Jonas Coronavirus, covid 19, COVID-19, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Pandemic

COVID-19 Crisis Spurs Institute to Understand and Combat Health Disparities in Underserved Communities. Earvin “Magic” Johnson, five-time NBA champion, and New York State Senator Brian Benjamin Among Industry and Public Health Leaders to Join Institute Task Force.

Read more

Mount Sinai Announces First-of-its-Kind Center For Post-COVID Care

May 13, 2020 sarah Jonas Coronavirus, covid 19, COVID clinical teams, COVID recovery, Health, Health & Medicine, Health & Wellness, Icahn School of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Mount Sinai Hospital, Pandemic, Recovery, Science

Center to provide post-multidisciplinary care and psychosocial resources for patients recovering from pandemic disease

COVID-19 Registry and clinical trials component will define new standards of care for patients

Read more

← Previous